Arkolith/Insider Trading/ELTP/Form 4

Elite Pharmaceuticals Inc

EVP OperationsELITE PHARMACEUTICALS INC /NV/ (ELTP) · full profile →Form 4 · filed Aug 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$260K
Net Open-Market Flow
-$260K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2025Option exercise(M)2.5M$0.03$75K4.3M
Aug 22, 2025Sell(S)500K$0.52$260K1.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2025Option exercise(M)2.5M—$02.5M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-012347) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML